Simona Skerjanec

Insider Reports History

Location
San Diego, CA
Signature
/s/ Adam Grajewski, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Simona Skerjanec:

Company Role Class Num Shares Value Price $ Report Date Ownership
Avidity Biosciences, Inc. Director Common Stock 0 $0 $72.51 27 Feb 2026 Direct
IMMUNIC, INC. Director Stock Option 150,000 05 Jun 2025 Direct
Atrium Therapeutics, Inc. Director Stock Option (Right to Buy) 20,000 27 Feb 2026 Direct
Atrium Therapeutics, Inc. Director Common Stock 5,902 26 Feb 2026 Direct
Avidity Biosciences, Inc. Director Stock Option (Right to Buy) 0 27 Feb 2026 Direct

Insider Reports Filed by Simona Skerjanec

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000119312526085918-skerjanec-simona-2026-02-27 Atrium Therapeutics, Inc. 27 Feb 2026 1 $0 4 Director 02 Mar 2026, 18:00
RNA Avidity Biosciences, Inc. 27 Feb 2026 3 $0 4 Director 27 Feb 2026, 15:22
/report/000119312526077728-skerjanec-simona-2026-02-26 Atrium Therapeutics, Inc. 26 Feb 2026 0 $0 3 Director 26 Feb 2026, 18:10
RNA Avidity Biosciences, Inc. 10 Jun 2025 2 $0 4 Director 12 Jun 2025, 18:30
IMUX IMMUNIC, INC. 05 Jun 2025 1 $0 4 Director 09 Jun 2025, 16:08
IMUX IMMUNIC, INC. 22 Jul 2024 2 $0 4 Director 24 Jul 2024, 16:11
IMUX IMMUNIC, INC. 22 Jul 2024 0 $0 3 Director 24 Jul 2024, 16:10
RNA Avidity Biosciences, Inc. 14 May 2024 1 $0 4 Director 16 May 2024, 18:21
RNA Avidity Biosciences, Inc. 14 May 2024 0 $0 3 Director 16 May 2024, 18:15